The three-year research agreement has the objective of creating new treatments to replace expensive and limited options currently in place, mainly being dialysis or kidney transplantation.
兩家製藥公司三年研究協議的目標是要達到創造新的治療方法，用以取代目前昂貴及有限的選項、這些選項主要在透析或腎臟移植方面。